ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: LLY

Lilly gets a win in diabetes drug treatment, tops 3 current medicines

Lilly gets a win in diabetes drug treatment, tops 3 current medicines

October 22, 2012 7:53 pm by | 0 Comments

(Reuters) - Eli Lilly & Co's experimental once-weekly diabetes drug dulaglutide proved superior in late-stage clinical trials to three other widely used medicines that are dosed more frequently, the company ... Read more
Alzheimer’s disease treatments from Roche, Lilly get into global trials

Alzheimer’s disease treatments from Roche, Lilly get into global trials

October 10, 2012 11:50 am by | 1 Comments

(Reuters) - Roche Holding AG's experimental drug gantenerumab and Eli Lilly & Co's solanezumab have been chosen to be tested in a high-profile global Alzheimer's disease prevention trial, and a ... Read more
Lilly’s rheumatoid arthritis drug using JAK inhibitors gets positive 2b results

Lilly’s rheumatoid arthritis drug using JAK inhibitors gets positive 2b results

June 8, 2012 3:11 pm by | 0 Comments

Eli Lilly‘s (NYSE:LLY) rheumatoid arthritis treatment developed by drug developer Incyte (NASDAQ:INCY) using oral janus-associated kinases, or JAK, inhibitors, has produced positive phase 2b results, according to a company statement.The ... Read more
Cardinal Health, Eli Lilly collaborate on Alzheimer’s imaging agent

Cardinal Health, Eli Lilly collaborate on Alzheimer’s imaging agent

June 1, 2012 10:07 am by | 0 Comments

Cardinal Health (NYSE:CAH) will manufacture and distribute a radioactive imaging agent from Eli Lilly (NYSE:LLY) that could help doctors diagnose Alzheimer’s disease.The imaging agent, called Amyvid, is scheduled for commercial ... Read more
Physician satisfaction takes center of pharma’s new drug marketing practices

Physician satisfaction takes center of pharma’s new drug marketing practices

January 12, 2012 1:04 pm by | 0 Comments

GlaxoSmithKline (NYSE:GSK) isn’t the only big drug company overhauling how pharmaceutical sales representatives talk to doctors. Others are now adapting with new sales practices.GlaxoSmithKline last year made waves when it ... Read more
Medtronic and Eli Lilly join hands to combat Parkinson’s Disease

Medtronic and Eli Lilly join hands to combat Parkinson’s Disease

April 26, 2011 11:39 am by | 0 Comments

Medtronic (NYSE:MDT) and Eli Lilly (NYSE:LLY) announced Tuesday that the companies are collaborating to find a new treatment for Parkinson’s Disease.The partnership aims toresearch and develop a new approach to ... Read more
Veterinary products maker Aurora Pharmaceutical raising $5M

Veterinary products maker Aurora Pharmaceutical raising $5M

March 9, 2011 4:34 pm by | 0 Comments

Two Northfield, Minnesota veterinarians, Mike Strobel and Mark Werner, are in the process of raising $5 million for their two-year-old Aurora Pharmaceutical as they seek to develop niche veterinary medicine ... Read more
Eli Lilly to pay up to $800M for Alzheimer’s tracing agent maker

Eli Lilly to pay up to $800M for Alzheimer’s tracing agent maker

November 8, 2010 7:25 pm by | 0 Comments

Indianapolis drug maker Eli Lilly & Co. (NYSE:LLY) has agreed to pay up to $800 million for Avid Radiopharmaceuticals, the Philadelphia developer of a tracing agent that can help diagnose ... Read more